Until very recently, Biosignatures has been keeping its activities quiet (some investors would refer to this as "stealth mode").

Over the course of 2011 we expect to be making more of the work we have done and the impressive results we have achieved public.

We presented the results of the project we did with Transgenomic Inc, University of Nebraska at Omaha & University of Thessaly Medical School, Greece September 2010 at the World Parkinson's Congress.

Will Dracup from Biosignatures is chairing the Diagnostics Stream and speaking on the panel in the Diagnostics Stream at the 6th Biomarker Congress, 23-24 Feb 2011, Manchester.